Injective price prediction: Can buybacks and technical support hold? INJ gains 7.43%

Traders Union
All News
Crypto News
Injective jumps 7.43% today to $3.34

Highlights

Injective completed its 226th Community Buyback, reducing INJ token supply to reinforce deflationary tokenomics and support long-term token scarcity.
Buybacks are a core element of Injective's economic framework, aiming to maintain scarcity while enhancing DeFi and decentralized derivatives platform stability.
INJ trades at $3.34, with near-term resistance at $3.63 and support at $3.28; technicals show ongoing bearish momentum and likely sideways consolidation between $3.00–$3.60.

Deflationary buybacks reinforce long-term scarcity strategy

Injective recently completed its 226th Community Buyback program round, which is designed to reduce the circulating supply of INJ tokens and support the platform's deflationary tokenomics. This regular buyback initiative reflects Injective's commitment to maintaining its economic framework and fostering long-term scarcity for the token. As a layer-1 blockchain focused on DeFi and decentralized derivatives, Injective incorporates these buybacks as a central pillar within its ecosystem.

Sustained seller control as momentum and support levels weaken

Momentum signals for INJ remain negative, with both the MACD and ADX confirming ongoing bearish conditions on the daily chart, while a strong trend persists according to the ADX. The RSI is hovering near oversold territory at 31.93, the Stochastic RSI is neutral, and the CCI also indicates modest selling, with Bull/Bear Power staying negative — together, these readings highlight continued intraday seller dominance despite minor rebounds. The nearest dynamic resistance can be found at the Ichimoku Kijun level at $3.63, while immediate support has formed near the MA-20.

Low rebound odds as consolidation and downside risks dominate

Over the next five trading days, INJ is expected to fluctuate between $3.00 and $3.60, a typical volatility band relative to current levels. The likelihood of a price rise remains low (below 20%), indicating greater risk of downside action. The baseline scenario is sideways consolidation, with INJ trading near short-term support and resistance. A breakout above $3.63 would suggest the potential for recovery toward the $3.80 – $4.00 range, while a move below $3.00 could accelerate declines toward the mid-$2.80 level.

Viktoras Karapetjanc, Traders Union expert, notes that Injective’s ongoing buyback program and robust tokenomics underpin the platform’s long-term value proposition. He sees current pricing and technicals as evidence of persistent bearish pressure, but highlights the positive sentiment from steady deflationary efforts. Near-term, Karapetjanc believes the likelihood of a strong upward move is limited, given negative momentum and ongoing resistance near $3.63. He expects a sideways range, with support at $3.28 and risk to the downside if $3.00 is breached. "The fundamentals remain constructive, and if sentiment shifts, INJ could quickly pivot higher—so active monitoring is warranted in this consolidation phase."

Previously it was reported that Injective Protocol continues to face strong bearish pressure, with the price trading well below its main weekly moving averages and major technical indicators—including MACD, ADX, and RSI—showing sustained downside momentum and oversold conditions. The asset is expected to consolidate in a narrow range near support around $2.80, with further declines likely if this support fails and no significant recovery expected unless resistance at $3.68 is decisively breached.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.